drugset / Trial / NCT02180828

Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis

NCT02180828

Phase 4 Completed 240 enrolled Peking University Shenzhen Hospital Bayer · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The study is focused to prove that the efficacy and safety of Clotrimazole vaginal tablet vs Fluconazole for the treatment of severe vulvovaginal candidiasis

Timeline

Start
2014-07
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Clotrimazole Unknown 500 mg Other
Comparator Fluconazole Small molecule 150 mg Oral